InfraVia Capital Partners acquired a minority stake in Univet from Platina Equity Solutions, which had been a partner since 2018. The transaction was structured as a combination of secondary share purchases and a primary capital increase, financed entirely through equity from InfraVia's EUR5 billion European Fund V. The founding management and associated veterinarians retained the majority of the capital. The investment is intended to accelerate Univet's buy-and-build strategy, supporting its ambition to reach EUR100 million in revenue by the end of 2022. This deal highlights the trend of infrastructure funds entering the veterinary sector, attracted by the predictable, recurring nature of animal healthcare services and the massive potential for market consolidation.

The transaction values UNIVET at an EV/Revenue multiple of LOGIN.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.